Zimmer Partners With EFORT FOUNDATION on 2010 Visiting Fellowship Program

MADRID, June 3, 2010 - Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today announced a new partnership with the EFORT (European Federation
of National Associations of Orthopaedics and Traumatology) FOUNDATION to
further educational opportunities for young orthopaedic surgeons. Zimmer will
provide 120,000 euro to the EFORT FOUNDATION Visiting Fellowship Program,
which will award grants to 40 visiting fellows from Europe to learn about new
techniques in practical orthopaedics, trauma science and pathophysiology.

The grants are specifically intended for post-graduate surgeons
specializing in Adult Reconstructive Orthopaedics (Knee, Hip, Shoulder, and
Elbow) and Trauma. Each fellow will have an opportunity to spend four to six
weeks at selected European centers, where they will be exposed to a high
volume of surgical cases and coaching from experts. Each fellowship grant of
3,000 euro is intended to help cover travel and living expenses for the
selected candidates.

"At a time when public and non-corporate private funding required for the
education of the next generation of medical professionals is under increasing
pressure, Zimmer believes that it is vital that industry share in the
commitment to advancing patient care," said Bruno Melzi, Chairman, Europe,
Middle East and Africa. "The 2010 Visiting Fellowship Program is aligned with
Zimmer's commitment to medical education and we're excited to partner with
the EFORT FOUNDATION to support the training of the next generation of
orthopaedic surgeons."

Established by EFORT in June 2009, the EFORT FOUNDATION is a non-profit
organization focused on financing research and education initiatives in the
fields of orthopaedics and trauma. The organization aims to become one of the
preferred partners for the funding of musculoskeletal research to improve the
clinical standard of orthopaedic and trauma care in Europe.

For details about the 2010 Visiting Fellowship Program, please visit
www.efort.org/about/foundation.fellowship.aspx

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs,
develops, manufactures and markets orthopaedic reconstructive, spinal and
trauma devices, dental implants, and related surgical products. Zimmer has
operations in more than 25 countries around the world and sells products in
more than 100 countries. Zimmer's 2009 sales were approximately US$4.1
billion. The Company is supported by the efforts of more than 8,000 employees
worldwide.

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about the
orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as "may," "will," "expects," "believes,"
"anticipates," "plans," "estimates," "projects," "assumes," "guides,"
"targets," "forecasts," and "seeks" or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. For a list and description of such risks and uncertainties, see
our periodic reports filed with the U.S. Securities and Exchange Commission.
We disclaim any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as may be set forth in our periodic reports.
Readers of this document are cautioned not to place undue reliance on these
forward-looking statements, since, while we believe the assumptions on which
the forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.

Media, Sabine Ciccotosto, +41-(0)52-262-72-41, sabine.ciccotosto at zimmer.com; or Investors, Paul Blair, +1-574-371-8042, paul.blair at zimmer.com, or James T. Crines, +1-574-372-4264, james.crines at zimmer.com